Adage Capital Management, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
LXEO
Shares outstanding
33,993,286 shares
Disclosed Ownership
237,953 shares
Ownership
0.7%
Form type
SCHEDULE 13G/A
Filing time
12 May 2025, 09:00:46 UTC
Date of event
31 Mar 2025
Previous filing
12 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 0.7% ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO) on 31 Mar 2025."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO).
  • Disclosed ownership: 0.7%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 12 Feb 2025.
  • Current filing was accepted on 12 May 2025, 09:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 0.7% 237,953 0 237,953 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 0.7% 237,953 0 237,953 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 0.7% 237,953 0 237,953 /s/ Phillip Gross Phillip Gross, individually

Sponsored